Shionogi Obtains Manufacturing, Marketing Approval for OXINORM Powder 0.5%.Tokyo, Japan, Oct 20, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Shionogi & Co., Ltd. today announced that it has received manufacturing and marketing approval on October 20 for OXINORM powder 0.5% (oxycodone hydrochloride hydrate hydrate (hī`drāt), chemical compound that contains water. A common hydrate is the familiar blue vitriol, a crystalline form of cupric sulfate. Chemically, it is cupric sulfate pentahydrate, CuSO4·5H2O. ), a powder analgesic analgesic (ăn'əljē`zĭk), any of a diverse group of drugs used to relieve pain. Analgesic drugs include the nonsteroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, narcotic drugs such as morphine, and synthetic drugs for pain associated with cancer. Shionogi plans to launch OXINORM in February 2007, after its National Health Insurance (NHI NHI abbr. National Health Insurance ) price listing. Licensed from Netherlands-based Mundipharma B.V., OXINORM powder 0.5% has the same composition as OxyContin Ox·y·con·tin A trademark for the drug oxycodone. oxycodone hydrochloride ETH-Oxydose, OxyContin, OxyFast, Oxy-IR, Oxynorm (UK), Roxicodone, Supeudol (CA) Pharmacologic class: Opioid agonist tablets, which Shionogi launched in July 2003. Shionogi has developed the powder as an immediate-release analgesic for combined use with OxyContin tablets, when dosage adjustment is needed or sudden pain (breakthrough pain) occurs. The World Health Organization (WHO) recommends treating cancer pain though combined use of sustained-release and immediate-release analgesics with the same composition and administration route. The approval of OXINORM powder 0.5% will enable more effective management of cancer pain in combination with OxyContin tablets. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion